3374-05-8
3374-05-8 結(jié)構(gòu)式
基本信息
1-乙基-1,4-二氫-7-甲基-4-氧代-1,8-萘啶-3-羧酸鈉鹽
萘啶酮酸鈉
NALIDIXIC ACID SODIUM SALT
1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylicacidsodium
8-naphthyridine-3-carboxylicacid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-sodiu
nalidixatesodium
sodiumnalidixate
sodiumnilixalate
nalidixic acid sodium
nalidixic acid sodium gamma-irradiated*molecular
sodium 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
NALIDIXIC ACID SODIUM GAMMA-IRRADIATED*M OLECULAR BI
NALIDIXIC ACID SODIUM SALT MOLECULAR BIOLOGY REAGENT
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, sodium salt
1,4-Dihydro-1-ethyl-4-oxo-7-methyl-1,8-naphthyridine-3-carboxylic acid sodium salt
1-Ethyl-4-oxo-7-methyl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid sodium salt
物理化學性質(zhì)
安全數(shù)據(jù)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/02/08 | HY-B0398A | 萘啶酮酸鈉 Nalidixic acid sodium salt | 3374-05-8 | 10 mg | 170元 |
| 2025/02/08 | HY-B0398A | 萘啶酮酸鈉 Nalidixic acid sodium salt | 3374-05-8 | 25 mg | 250元 |
| 2025/02/08 | HY-B0398A | 萘啶酮酸鈉 Nalidixic acid sodium salt | 3374-05-8 | 50 mg | 350元 |
常見問題列表
|
Topoisomerase
|
Nalidixic acid is against a variety of microorganisms, it is against with Escherichia coli , Pasteurella spp. , Klebsiella pneuiiioniae , Aerobacter aeroyenes , Proteus spp. , Salmonella spp. , Shigella spp. and Brucella spp. with MIC values of 5.0-12.5 μg/ml, 0.5-2.5 μg/ml, 0.8-25.0 μg/ml, 1.0-25.0 μg/ml, 1.25-30.0 μg/ml, 8-3.2 μg/ml, and 7.5-10.0 μg/ml, respectively.
The in vivo activity of Nalidixic acid is most pronounced against Gram-negative bacteria, while Gram-positive organisms are generally more resistant. Maximal activity is observed against systemic infections caused by E. coli , A. aerobacter , Proteus mirabilis , Shigella fkxneri , the ED 50 values are 25 mg/kg, 60 mg/kg, 50 mg/kg, and 62 mg/kg, respectively. The acute toxicity (LD 50 ) of Nalidixic acid in mice following oral and parenteral administration is: oral, 3300 mg/kg; intravenous, 176 mg/kg; and subcutaneous, 500 mg/kg.